Effect of Fufang Danshen Tablets and Clopidogrel on Platelet Activation in Hyperlipidemic Mice

ZHU Yan-fang1; ZHU Wei2

doi:10.13422/j.cnki.syfjx.2012.15.083

您当前的位置：

首页 >

文章列表页 >

Effect of Fufang Danshen Tablets and Clopidogrel on Platelet Activation in Hyperlipidemic Mice

更新时间：2024-09-23

- Effect of Fufang Danshen Tablets and Clopidogrel on Platelet Activation in Hyperlipidemic Mice
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 18, Issue 15, Pages: 175-178(2012)
- 作者机构：
  
  1. 广州中医药大学中医病机与治法研究实验室
  2. 广州中医药大学第二临床医学院
  3. 广东省中医药科学院
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2012.15.083
  CLC： R589.2
- Published：2012
- 稿件说明：
移动端阅览
[1]朱艳芳,朱伟.复方丹参片和氯吡格雷联合使用对高血脂症小鼠血小板活化功能的影响[J].中国实验方剂学杂志,2012,18(15):175-178.

ZHU Yan-fang1, ZHU Wei2. Effect of Fufang Danshen Tablets and Clopidogrel on Platelet Activation in Hyperlipidemic Mice[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(15): 175-178.
[1]朱艳芳,朱伟.复方丹参片和氯吡格雷联合使用对高血脂症小鼠血小板活化功能的影响[J].中国实验方剂学杂志,2012,18(15):175-178. DOI： 10.13422/j.cnki.syfjx.2012.15.083.

ZHU Yan-fang1, ZHU Wei2. Effect of Fufang Danshen Tablets and Clopidogrel on Platelet Activation in Hyperlipidemic Mice[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(15): 175-178. DOI： 10.13422/j.cnki.syfjx.2012.15.083.

摘要

目的:观察复方丹参片和氢氯吡格雷联合使用对高血脂症小鼠血小板活化功能的影响

并探讨其分子机制。方法:健康昆明种小鼠50只

随机分为正常对照组、模型对照组、模型+氯吡格雷组（21 mg·kg-1.d-1）、模型+复方丹参片组（160 mg·kg-1.d-1）、模型+联合用药组（氯吡格雷21 mg·kg-1.d-1+复方丹参片160 mg·kg-1.d-1）5组

每组动物10只。ig给药2周后摘眼球采血

分离血清

测定各组小鼠血清总胆固醇（TC）、甘油三脂（TG）、高密度脂蛋白胆固醇（HDL-C）、低密度脂蛋白胆固醇（LDL-C）水平

流式细胞仪检测各组小鼠的血小板活化功能。结果:氯吡格雷和复方丹参片对高血脂症小鼠的体重没有影响

氯吡格雷可显著降低高血脂症小鼠TC和LDL-C水平（P<0.05）。复方丹参片可显著降低高血脂症小鼠TC、TG和LDL-C水平（P<0.01或P<0.05）。高血脂症小鼠活化血小板比率（45.75±6.94）%

明显高于正常对照组（28.02±5.86）%

（P<0.01）。氯吡格雷均可显著降低高血脂症小鼠的活化血小板比率和中性粒细胞-血小板聚集率（P<0.01或P<0.05）

复方丹参片可显著增强氯吡格雷降低高血脂症小鼠活化血小板比率、中性粒细胞-血小板聚集率和单核细胞-血小板聚集率的作用（25.19%±4.16%）vs（32.48%±4.74%）;（8.64%±2.69%）vs（11.46%±2.33%）;（20.12%±4.65%）vs（24.74%±4.67%）

（P<0.01或P<0.05）。结论:高血脂症小鼠的血小板处于高活化状态

复方丹参片和氯吡格雷联合使用具有协同效应

复方丹参片能显著增强氯吡格雷抑制血小板活性的作用。

Abstract

Objective: To study the effect of Fufang Danshen tablets and clopidogrel on the platelet activation in hyperlipidemic mice and its mechanism.Method: Fifty healthy Kunming mice were randomly divided into five groups: normal diet control group

high fat diet control group

clopidogrel gavage group

Fufang Danshen tablets gavage group and combined therapy gavage group.After administration of two weeks

the mice were killed and the blood samples were collected for the determination of serum total cholesterol（TC）

triglyceride（TG）

high-density lipoprotein cholesterol（HDL-C）

low-density lipoprotein cholesterol（LDL-C） and function of platelets.Result: Either clopidogrel or Fufang Danshen tablets had no effect on body weight in hyperlipidemic mice.Clopidogrel could significantly reduce the elevated TC and LDL-C of hyperlipidemic mice（P<0.05）.Fufang Danshen tablets could significantly reduce the elevated TC

TG and LDL-C in hyperlipidemic mice（P<0.05 or P<0.01）.The activated platelets ratio（45.75±6.94）% in hyperlipidemic mice was significantly higher than that in control group（28.02±5.86）%（P<0.01）.Clopidogrel could significantly reduce the elevated activated platelets ratio and neutrophil-platelet aggregation ratio in hyperlipidemic mice（P<0.01）.Fufang Danshen tablets could significantly increase the inhibitory effect of clopidogrel on the elevated activated platelets ratio

neutrophil-platelet aggregation ratio and monocyte-platelet aggregation ratio in hyperlipidemic mice（25.19%±4.16%） vs（32.48%±4.74%）

（8.64%±2.69%） vs（11.46%±2.33%）

（20.12%±4.65%） vs（24.74%±4.67%）

（P<0.01 or P<0.05）.Conclusion: The platelet in hyperlipidemic mice is highly activated.The comnined clopidogrel and Fufang Danshen tablets have synergistic effect.Fufang Danshen tablets can significantly enchance the inhibitory effect of clopidogrel on function of platelets in hyperlipidemic mice.

关键词

Keywords

references

Views

276

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Efficacy of Zhuyuwan in Treatment of Hyperlipidemia with Syndrome of Phlegm Turbidity and Obstruction

Zhuyuwan in Treatment of Hyperlipidemia Complicated with Carotid Atherosclerosis： A Randomized Controlled Trial

Mechanism of Wendantang in Intervention of ApoE^-/- Hyperlipidemic Mice Based on Liver Metabolomics

Polygonati Odorati Rhizoma Polysaccharides Ameliorate Hyperlipidemia in Mice by Regulating Gut Microbiota

Related Author

ZHU Yan-fang

ZHU Wei

YANG Lele

LUO Danmei

CHEN Jiao

ZHANG Xiaobo

SONG Wei

ZHU Wenyu

Related Institution

Chengdu University of TCM

Hospital of Chengdu University of Traditional Chinese Medicine （TCM）

Hospital of Chengdu University of TCM

Chengdu University of Traditional Chinese Medicine（TCM）

Research Center for Differentiation and Development of Traditional Chinese Medicine （TCM） Basic Theory/Jiangxi Province Key Laboratory of Biological Etiologies of TCM/First-Level Discipline Platform of Chinese and Western Integrative Medicine/Experimental Animal and Scientific Technology Center of Jiangxi University of Chinese Medicine/School of Pharmacy， Jiangxi University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰